Loading...
Structural Polymorphism of Sorafenib Tosylate as a Key Factor in Its Solubility Differentiation
The presence of active pharmaceutical ingredients (APIs) in the forms of different polymorphic states can induce differences in their physicochemical properties. In the case of poorly soluble APIs, like the oncological drug sorafenib tosylate, small variations in solubility may result in large bioav...
Na minha lista:
| Udgivet i: | Pharmaceutics |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
MDPI
2021
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8002161/ https://ncbi.nlm.nih.gov/pubmed/33805754 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pharmaceutics13030384 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|